tirzepatide autoimmune disease GLP-1 Agonists in GLP-1 Drugs: Ozempic, Mounjaro, Zepbound:
Description
Clinical data supports this
Insulin sensitivity: In addition to increasing insulin secretion, there is emerging evidence that GIPR agonism could also increase peripheral insulin sensitivity
What it is: Day-old sushi
Tirzepatide activates GLP-1 receptors, but its more accurately classified as a dual GIP/GLP-1 receptor agonist that targets two hormonal pathways instead of one
A strong move that reinforces Sandozs ambition to shape the future of access in metabolic disease
Full disclosure Affiliate link we may earn a commission if you enroll
